Risk factor
Very poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Gradiant Corporation, together with its subsidiaries, engages in e-commerce business in South Korea, Vietnam, China, and internationally. It operates through Holding Business; Industrial B2B E-Commerce Business; Bio Healthcare Business; and Other Business segments. The company focuses on life sciences and healthcare, environment and energy, and creative learning platform businesses. It offers EV charging, organoids, venture capital funding for the biotech sector, advertising, and logistics agency services, as well as an online creative learning platform. The company also procures and distributes pharmaceutical drugs and medical supplies to hospitals; develops oncology drugs; develops, manufactures, and commercializes adhesive films for electronic devices, such as smartphones; and supplies MRO and industrial consumables goods through the internet. In addition, it is involved in investing, consulting, and freight transportation brokerage and agency activities. The company was formerly known as Interpark Co., Ltd. and changed its name to Gradiant Corporation in February 2022. Gradiant Corporation was founded in 1995 and is headquartered in Seoul, South Korea.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. In particular, the stock is 'cheap' on EV/EBITDA.
Buy
Sell